Maxcyte (MXCT) Change in Acquisitions & Divestments (2020 - 2026)

Maxcyte (MXCT) has reported Change in Acquisitions & Divestments for 7 consecutive years, with $18.0 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Change in Acquisitions & Divestments fell 41.94% year-over-year to $18.0 million in Q2 2026; TTM through Jun 2026 was $124.2 million, a 18.1% decrease from a year earlier, with the FY2025 full-year figure at $155.8 million, down 2.31% from the prior year.
• Change in Acquisitions & Divestments was $18.0 million for Q2 2026 at Maxcyte, down from $28.0 million in the prior quarter.
• Over five years, Change in Acquisitions & Divestments peaked at $200.8 million in Q1 2022 and troughed at $6.5 million in Q2 2022.
• A 5-year average of $53.3 million and a median of $41.5 million in 2024 frame the typical range for Change in Acquisitions & Divestments.
• Across the five-year window, Change in Acquisitions & Divestments jumped 1154.97% in 2022 and slumped 61.29% in 2024, its largest moves.
• Over 5 years, Change in Acquisitions & Divestments stood at $52.5 million in 2022, then climbed by 26.19% to $66.2 million in 2023, then plunged by 53.21% to $31.0 million in 2024, then grew by 23.1% to $38.2 million in 2025, then sank by 52.83% to $18.0 million in 2026.
• The last three Change in Acquisitions & Divestments figures came in at $18.0 million (Q2 2026), $28.0 million (Q1 2026), and $38.2 million (Q4 2025), per Business Quant data.